Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Hair loss gene linked to prostate issues.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Hair loss, known as androgenic alopecia, can start in teenage years and may not always be hormone-related. It's important to do extra tests in young cases and remember it can greatly affect a teenager's mental health.

Androgen levels do not determine the type of PCOS symptoms in young females.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.